16-3242296-G-A

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBS1_SupportingBS2

The NM_000243.3(MEFV):​c.*845C>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00997 in 110,518 control chromosomes in the GnomAD database, including 15 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).

Frequency

Genomes: 𝑓 0.011 ( 14 hom., cov: 25)
Exomes 𝑓: 0.0011 ( 1 hom. )

Consequence

MEFV
NM_000243.3 3_prime_UTR

Scores

2

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:2

Conservation

PhyloP100: 0.355

Publications

0 publications found
Variant links:
Genes affected
MEFV (HGNC:6998): (MEFV innate immunity regulator, pyrin) This gene encodes a protein, also known as pyrin or marenostrin, that is an important modulator of innate immunity. Mutations in this gene are associated with Mediterranean fever, a hereditary periodic fever syndrome. [provided by RefSeq, Jul 2008]
MEFV Gene-Disease associations (from GenCC):
  • familial Mediterranean fever
    Inheritance: AD, AR, SD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, Myriad Women’s Health, ClinGen
  • autosomal recessive familial Mediterranean fever
    Inheritance: AR Classification: DEFINITIVE Submitted by: G2P
  • familial Mediterranean fever, autosomal dominant
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.94).
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0115 (1084/94368) while in subpopulation AFR AF = 0.0403 (921/22854). AF 95% confidence interval is 0.0381. There are 14 homozygotes in GnomAd4. There are 515 alleles in the male GnomAd4 subpopulation. Median coverage is 25. This position passed quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High Homozygotes in GnomAd4 at 14 AR,AD,SD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MEFVNM_000243.3 linkc.*845C>T 3_prime_UTR_variant Exon 10 of 10 ENST00000219596.6 NP_000234.1 O15553-2
MEFVNM_001198536.2 linkc.*1395C>T 3_prime_UTR_variant Exon 9 of 9 NP_001185465.2 O15553-3D2DTW2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MEFVENST00000219596.6 linkc.*845C>T 3_prime_UTR_variant Exon 10 of 10 1 NM_000243.3 ENSP00000219596.1 O15553-2

Frequencies

GnomAD3 genomes
AF:
0.0115
AC:
1083
AN:
94326
Hom.:
15
Cov.:
25
show subpopulations
Gnomad AFR
AF:
0.0403
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00427
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00427
Gnomad NFE
AF:
0.00250
Gnomad OTH
AF:
0.00701
GnomAD2 exomes
AF:
0.00
AC:
0
AN:
100
AF XY:
0.00
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00111
AC:
18
AN:
16150
Hom.:
1
Cov.:
0
AF XY:
0.000855
AC XY:
9
AN XY:
10524
show subpopulations
African (AFR)
AF:
0.0102
AC:
1
AN:
98
American (AMR)
AF:
0.00276
AC:
1
AN:
362
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
238
East Asian (EAS)
AF:
0.00
AC:
0
AN:
44
South Asian (SAS)
AF:
0.000903
AC:
6
AN:
6648
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
1044
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
36
European-Non Finnish (NFE)
AF:
0.00127
AC:
9
AN:
7086
Other (OTH)
AF:
0.00168
AC:
1
AN:
594
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.472
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0115
AC:
1084
AN:
94368
Hom.:
14
Cov.:
25
AF XY:
0.0113
AC XY:
515
AN XY:
45634
show subpopulations
African (AFR)
AF:
0.0403
AC:
921
AN:
22854
American (AMR)
AF:
0.00427
AC:
37
AN:
8662
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2292
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3070
South Asian (SAS)
AF:
0.00
AC:
0
AN:
1992
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6944
Middle Eastern (MID)
AF:
0.00450
AC:
1
AN:
222
European-Non Finnish (NFE)
AF:
0.00250
AC:
116
AN:
46336
Other (OTH)
AF:
0.00696
AC:
9
AN:
1294
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
47
94
140
187
234
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00613
Hom.:
0
Bravo
AF:
0.00829

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Uncertain:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Familial Mediterranean fever Uncertain:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.94
CADD
Benign
4.6
DANN
Benign
0.37
PhyloP100
0.35
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs371608683; hg19: chr16-3292296; API